Bd reports first quarter fiscal 2025 financial results

Company delivers revenue, margin and earnings ahead of its expectations revenue of $5.2 billion increased 9.8% as reported, 9.6% currency-neutral and 3.9% organic gaap and adjusted diluted eps of $1.04 and $3.43 grew 8.3% and 28.0%, respectively bd completes $750 million share repurchase to date in fy25 company increases fy25 adjusted diluted eps guidance at the midpoint while absorbing translational currency1 franklin lakes, n.j. , feb. 5, 2025 /prnewswire/ -- bd (becton, dickinson and company) (nyse: bdx), a leading global medical technology company, today announced results for its fiscal 2025 first quarter which ended december 31, 2024.
BDX Ratings Summary
BDX Quant Ranking